76
|
Knight E, Shapiro A, Lu ZL. Drastically different percepts of five illusions in foveal and peripheral vision reveal their differences in representing visual phase. J Vis 2010. [DOI: 10.1167/8.6.967] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
77
|
Shapiro A, Lu ZL. Long-range argyles and spatial-scale models of brightness. J Vis 2010. [DOI: 10.1167/9.8.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
78
|
Shapiro A, Knight E, Lu ZL. Spatial scale models of lightness illusions: contrast, anchoring, and tunable filters. J Vis 2010. [DOI: 10.1167/8.6.288] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
79
|
Emamaullee J, Gullipalli R, Montana-Loza A, Toso C, Shapiro A, Owen R. The Efficacy of Transarterial Radioembolization and Transarterial Chemoembolization in Hepatocellular Carcinoma: Effect on Total Tumor Volume and Patient Survival at a Single Center. J Surg Res 2010. [DOI: 10.1016/j.jss.2009.11.609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
80
|
Shapiro A, Redmond M, Mitchell L, Chung C, Shah H, Hahn S, Bogart J, Canute G. Repeated Stereotactic Radiosurgery for Recurrent Brain Metastases is Safe and Effective. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
81
|
Abstract
Hereditary haemorrhagic telangiectasia (also known as Osler-Weber-Rendu syndrome) is a relatively common, under-recognized autosomal-dominant disorder that results from multisystem vascular dysplasia. It is characterized by telangiectases and arteriovenous malformations of skin, mucosa and viscera. This article summarizes the clinical manifestations and the management of this disorder and its management. This review underscores an urgent need to conduct prospective multicentre studies to develop evidence-based management guidelines for this disease.
Collapse
|
82
|
Kulkarni R, Soucie JM, Lusher J, Presley R, Shapiro A, Gill J, Manco-Johnson M, Koerper M, Mathew P, Abshire T, Dimichele D, Hoots K, Janco R, Nugent D, Geraghty S, Evatt B. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia 2009; 15:1281-90. [PMID: 19637999 DOI: 10.1111/j.1365-2516.2009.02074.x] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Lack of detailed natural history and outcomes data for neonates and toddlers with haemophilia hampers the provision of optimal management of the disorder. We report an analysis of prospective data collected from 580 neonates and toddlers aged 0-2 years with haemophilia enrolled in the Universal Data Collection (UDC) surveillance project of the Centers for Disease Control and Prevention (CDC). This study focuses on a cohort of babies with haemophilia whose diagnosis was established before the age of two. The mode of delivery, type and severity of haemophilia, onset and timing of haemorrhages, site(s) of bleeding, provision of prophylaxis with coagulation factor replacement therapy, and the role played by the federally funded Haemophilia Treatment Centers (HTC) in the management of these infants with haemophilia were evaluated. Seventy-five per cent of haemophilic infants were diagnosed early, in the first month of life, especially those with a family history or whose mothers were known carriers; infants of maternal carriers were more likely to be delivered by C-section. Involvement of an HTC prior to delivery resulted in avoidance of the use of assisted deliveries with vacuum and forceps. Bleeding from the circumcision site was the most common haemorrhagic complication, followed by intra- and extra-cranial haemorrhages and bleeding from heel stick blood sampling. Eight per cent of the infants were administered factor concentrate within 24 h of birth; more than half were treated to prevent bleeding. This study highlights the significant rate and the sites of initial bleeding unique to very young children with haemophilia and underscores the need for research to identify optimal evidence-based recommendations for their management.
Collapse
|
83
|
Hsie M, Chung C, Hahn S, Shah H, Hodge C, Canute G, Montgomery C, Shapiro A. Quality of Life in Patients Treated with Repeat Gamma Knife Radiosurgery for Recurrent or Refractory Trigeminal Neuralgia. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
84
|
Sharathkumar A, Hardesty B, Greist A, Salter J, Kerlin B, Heiman M, Sulkin M, Shapiro A. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation. Haemophilia 2008; 15:91-100. [PMID: 18721150 DOI: 10.1111/j.1365-2516.2008.01792.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The aim of this study was to characterize the variability of bleeding phenotype and its association with plasma factor IX coagulant activity (FIX:C) in haemophilia B carriers in a large Amish pedigree with a unifying genetic mutation, C-to-T transition at base 31008 of the factor IX gene (Xq27.1-27.2). A cross-sectional survey of haemophilia B carriers included a multiple choice questionnaire evaluating symptoms of mucocutaneous bleeding, joint bleeding and bleeding after haemostatic stress [menstruation, postpartum haemorrhage (PPH), dental extractions and invasive surgeries]. Severity of bleeding was graded as 0 to 4, 0 being no bleeding whereas 4 being severe bleeding. Association between total bleeding scores and the FIX:C was evaluated. Sixty-four haemophilia B carriers participated in this study. Median age: 18 years (range 1-70 years); median bleeding score: 1 (range 0-8). Besides PPH, isolated symptoms of bruising, epistaxis, menorrhagia and postsurgical bleeding including dental extraction were not associated with lower FIX:C. Bleeding score >/=3 was associated with involvement of at least two bleeding sites and a lower mean FIX:C of 42 +/- 10.3% (95% CI 36.4-47.7) while a score >3 had involvement of </=2 sites and higher mean FIX:C of 54.9 +/- 21.5% (95% CI 49-61), P = 0.005. Subcutaneous haematoma formation and bleeding after haemostatic stress requiring treatment were associated with bleeding scores >/=3. Phenotypic variability existed among the carriers of haemophilia B who belonged to a single pedigree carrying a single unifying mutation. The utility of bleeding scores to define bleeding phenotype precisely in haemophilia B carriers needs further evaluation.
Collapse
|
85
|
Bonnett I, Busigin A, Shapiro A. Tritium Removal and Separation Technology Developments. FUSION SCIENCE AND TECHNOLOGY 2008. [DOI: 10.13182/fst08-a1797] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
86
|
Shapiro A. Delinquent and disturbed behaviour within the field of mental deficiency. INTERNATIONAL PSYCHIATRY CLINICS 2008; 5:76-90. [PMID: 4886274 DOI: 10.1002/9780470719640.ch6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
87
|
Chlebowski RT, Blackburn GL, Hoy MK, Thomson CA, Giuliano AE, McAndrew P, Hudis CA, Butler J, Shapiro A, Elashoff RM. Survival analyses from the Women's Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.522] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
88
|
|
89
|
Sharthkumar A, Greist A, Di Paola J, Winay J, Roberson C, Heiman M, Herbert S, Parameswaran R, Shapiro A. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease. Haemophilia 2008; 14:539-48. [PMID: 18312368 DOI: 10.1111/j.1365-2516.2008.01666.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The aim of this study was to characterize the adequacy and longevity of biological response to desmopressin (DDAVP) in a large Amish kindred of Type 2M von Willebrand disease (VWD) possessing C-to-T transition at nucleotide 4120 in exon 28 of A1 domain of von Willebrand factor (VWF) gene. Response to both intranasal (Stimate) and subcutaneous DDAVP administration was assessed. Rise in ristocetin cofactor activity (VWF:RCo) > or = 40% at 90-min post-Stimate and 1-2 h after subcutaneous DDAVP was defined as initial response; response longevity was assessed only after subcutaneous dosing by measuring VWF:RCo levels at time-points 1, 2, 4 and 6 h. Eleven patients (five males, six females; age range: 20-56 years) participated in intranasal and 9/11 (four males, five females) in subcutaneous testing. Baseline haemostatic profiles included: VWF:RCo < 15%, VWF:Ag < 40% and normal VWF multimers. Initial response was comparable by both intranasal (6/11; 54.5%) and subcutaneous (4/9; 44%) routes; sustained response (VWF:RCo > 40% for 2 h) was observed in only one in nine (11%) patients tested. Median VWF:RCo peak levels after intranasal (40%) and subcutaneous (39%) routes were equivalent. Peak VWF:Ag levels were significantly higher after subcutaneous than intranasal DDAVP (94% vs. 54%; P = 0.03). Area under the curve for VWF:RCo was significantly decreased (170 microg h mL(-1)) compared with VWF:Ag (471 microg h mL(-1)) and FVIII:C (624.60 microg h mL(-1)). This study suggests that in this population: (i) intra-individual DDAVP response is consistent with subcutaneous and intranasal administration; and (ii) extending DDAVP challenge test up to at least 6 h is required to characterize adequacy and longevity of biologic response prior to using DDAVP as a sole haemostatic intervention.
Collapse
|
90
|
Shapiro A, Gay H, Hahn S, Bogart J, Shah H, Chung C. Treatment Results for Non-Small Cell Lung Cancer Patients Presenting With Brain Metastases. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
91
|
Tencer T, Roberson C, Duncan N, Johnson K, Shapiro A. A haemophilia treatment centre-administered disease management programme in patients with bleeding disorders. Haemophilia 2007; 13:480-8. [PMID: 17880433 DOI: 10.1111/j.1365-2516.2007.01495.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The objective of this study is to describe a disease management programme (DMP) for the bleeding disorder population insured by Indiana's high-risk insurance plan, and to assess the associated costs and outcomes. All bleeding disorder patients, covered by the state plan as their primary health insurance, were enrolled into a DMP administered by the Indiana Hemophilia & Thrombosis Center (IHTC). A pre/post-intervention study design was used, with 1-year pre-enrollment serving as the baseline period and 1-year post-enrollment as the study period. Claims data were used to assess hospitalizations, emergency room (ER) visits, total medical and clotting factor costs and factor units dispensed. Medical records were used to assess disease severity and other comorbidities. Thirty-one continuously enrolled patients had complete data over 2 years. Approximately 84% of the population was male, 81% with haemophilia. The average costs of care in the baseline year and the first year of the programme were $161 441 and $118 293, respectively. The decrease in the total costs was primarily attributed to a decrease in outpatient factor costs, which resulted from decreased factor utilization and lower per unit factor costs. The mean number of inpatient hospital days and ER visits for the DMP population decreased from 1.3 and 1.4 to 0.4 and 0.6, baseline and first year, respectively. Owing to the small sample size and high variability of the population, the differences were not statistically significant. The DMP appears to have reduced the total costs and resource utilization, although the study was underpowered.
Collapse
|
92
|
Hidas G, Gofrit O, Katz R, Landau E, Shapiro A, Pode D. MP-08.03: Changes in the characteristics of patients and results of radical prostatectomy in the years 1990-2005. Urology 2007. [DOI: 10.1016/j.urology.2007.06.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
93
|
Soucie J, Miller C, Creary M, Hooper W, Abshire T, Brettler D, Bockenstedt P, DiPaola J, Massey G, Neff A, Shapiro A, Tarantino M, Wicklund B, DiMichele D. U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION. J Thromb Haemost 2007. [DOI: 10.1111/j.1538-7836.2007.tb01876.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
94
|
Bornheim A, Lipeles E, Pappas SP, Shapiro A, Sun WM, Weinstein AJ, Briere RA, Chen GP, Ferguson T, Tatishvili G, Vogel H, Adam NE, Alexander JP, Berkelman K, Blanc F, Boisvert V, Cassel DG, Drell PS, Duboscq JE, Ecklund KM, Ehrlich R, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hsu L, Jones CD, Kandaswamy J, Kreinick DL, Magerkurth A, Mahlke-Kruger H, Meyer TO, Mistry NB, Patterson JR, Peterson D, Pivarski J, Richichi SJ, Riley D, Sadoff AJ, Schwarthoff H, Shepherd MR, Thayer JG, Urner D, Wilksen T, Warburton A, Weinberger M, Athar SB, Avery P, Breva-Newell L, Potlia V, Stoeck H, Yelton J, Benslama K, Eisenstein BI, Gollin GD, Karliner I, Lowrey N, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Besson D, Zhao X, Anderson S, Frolov VV, Gong DT, Kubota Y, Li SZ, Poling R, Smith A, Stepaniak CJ, Urheim J, Metreveli Z, Seth KK, Tomaradze A, Zweber P, Ahmed S, Alam MS, Ernst J, Jian L, Saleem M, Wappler F, Arms K, Eckhart E, Gan KK, Gwon C, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, von Toerne E, Zoeller MM, Severini H, Skubic P, Dytman SA, Mueller JA, Nam S, Savinov V, Hinson JW, Lee J, Miller DH, Pavlunin V, Sanghi B, Shibata EI, Shipsey IPJ, Cronin-Hennessy D, Lyon AL, Park CS, Park W, Thayer JB, Thorndike EH, Coan TE, Gao YS, Liu F, Maravin Y, Stroynowski R, Artuso M, Boulahouache C, Blusk S, Bukin K, Dambasuren E, Mountain R, Muramatsu H, Nandakumar R, Skwarnicki T, Stone S, Wang JC, Mahmood AH, Csorna SE, Danko I, Bonvicini G, Cinabro D, Dubrovin M, McGee S. Publisher’s Note: Measurements of charmless hadronic two-bodyBmeson decays and the ratioB(B→DK)/B(B→Dπ)[Phys. Rev. D68, 052002 (2003)]. Int J Clin Exp Med 2007. [DOI: 10.1103/physrevd.75.119907] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
95
|
Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CRM, Hoots WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia 2006; 12 Suppl 6:1-7. [PMID: 17123387 DOI: 10.1111/j.1365-2516.2006.01359.x] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Participants in an international conference on the management of haemophilia patients with inhibitors developed a jointly authored summary of the findings and conclusions of the conference. Current knowledge of the genetic and immunologic mechanisms underlying inhibitor development was briefly summarized. Concerning the purported treatment-related risk factors, conference participants commented on the limitations of the available evidence and the need for more rigorous prospective research in a fully genotyped population. Other clinical considerations discussed included the unproved utility of routine surveillance, the need for assay standardization, the management of acute bleeding and approaches to joint disease prophylaxis and immune tolerance induction (ITI). A number of issues were identified as needing further investigation in larger prospective studies, ideally through international cooperation. Such studies should enroll cohorts that have been scrupulously defined in terms of mutation status and treatment exposure. Finally, conference participants urged their colleagues to participate in the currently ongoing international trials of ITI.
Collapse
|
96
|
Shapiro A, Flanagan S, Joannou A, Chen-Wong D, O’Kelly L, Conforti C. Poster 45. Arch Phys Med Rehabil 2006. [DOI: 10.1016/j.apmr.2006.07.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
97
|
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes. THE JOURNAL OF IMMUNOLOGY 2005; 175:4320-30. [PMID: 16177072 DOI: 10.4049/jimmunol.175.7.4320] [Citation(s) in RCA: 534] [Impact Index Per Article: 28.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
The specific signals mediating the activation of microglia and astrocytes as a prelude to, or consequence of, CNS inflammation continue to be defined. We investigated TLRs as novel receptors mediating innate immune responses in human glial cells. We find that microglia express mRNA for TLRs 1-9, whereas astrocytes express robust TLR3, low-level TLR 1, 4, 5, and 9, and rare-to-undetectable TLR 2, 6, 7, 8, and 10 mRNA (quantitative real-time PCR). We focused on TLRs 3 and 4, which can signal through both the MyD88-dependent and -independent pathways, and on the MyD88-restricted TLR2. By flow cytometry, we established that microglia strongly express cell surface TLR2; TLR3 is expressed at higher levels intracellularly. Astrocytes express both cell surface and intracellular TLR3. All three TLRs trigger microglial activation upon ligation. TLR3 signaling induces the strongest proinflammatory polarizing response, characterized by secretion of high levels of IL-12, TNF-alpha, IL-6, CXCL-10, and IL-10, and the expression of IFN-beta. CXCL-10 and IL-10 secretion following TLR4 ligation are comparable to that of TLR3; however, other responses were lower or absent. TLR2-mediated responses are dominated by IL-6 and IL-10 secretion. Astrocytes respond to TLR3 ligation, producing IL-6, CXCL-10, and IFN-beta, implicating these cells as contributors to proinflammatory responses. Initial TLR-mediated glial activation also regulates consequent TLR expression; while TLR2 and TLR3 are subject to positive feedback, TLR4 is down-regulated in microglia. Astrocytes up-regulate all three TLRs following TLR3 ligation. Our data indicate that activation of innate immune responses in the CNS is not homogeneous but rather tailored according to cell type and environmental signal.
Collapse
|
98
|
Chlebowski RT, Blackburn GL, Elashoff RE, Thomson C, Goodman MT, Shapiro A, Giuliano AE, Karanja N, Hoy MK, Nixon DW. Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women’s Intervention Nutrition Study (WINS). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.10] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
99
|
Hinson JW, Huang GS, Lee J, Miller DH, Pavlunin V, Rangarajan R, Sanghi B, Shibata EI, Shipsey IPJ, Cronin-Hennessy D, Park CS, Park W, Thayer JB, Thorndike EH, Coan TE, Gao YS, Liu F, Stroynowski R, Artuso M, Boulahouache C, Blusk S, Dambasuren E, Dorjkhaidav O, Mountain R, Muramatsu H, Nandakumar R, Skwarnicki T, Stone S, Wang JC, Csorna SE, Danko I, Bonvicini G, Cinabro D, Dubrovin M, McGee S, Bornheim A, Lipeles E, Pappas SP, Shapiro A, Sun WM, Weinstein AJ, Briere RA, Chen GP, Ferguson T, Tatishvili G, Vogel H, Watkins ME, Adam NE, Alexander JP, Berkelman K, Boisvert V, Cassel DG, Duboscq JE, Ecklund KM, Ehrlich R, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hsu L, Jones CD, Kandaswamy J, Kreinick DL, Magerkurth A, Mahlke-Krüger H, Meyer TO, Mistry NB, Patterson JR, Peterson D, Pivarski J, Richichi SJ, Riley D, Sadoff AJ, Schwarthoff H, Shepherd MR, Thayer JG, Urner D, Wilksen T, Warburton A, Weinberger M, Athar SB, Avery P, Breva-Newell L, Potlia V, Stoeck H, Yelton J, Benslama K, Cawlfield C, Eisenstein BI, Gollin GD, Karliner I, Lowrey N, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Besson D, Anderson S, Frolov VV, Gong DT, Kubota Y, Li SZ, Poling R, Smith A, Stepaniak CJ, Urheim J, Metreveli Z, Seth KK, Tomaradze A, Zweber P, Ahmed S, Alam MS, Ernst J, Jian L, Saleem M, Wappler F, Arms K, Eckhart E, Gan KK, Gwon C, Honscheid K, Kagan H, Kass R, Pedlar TK, von Toerne E, Severini H, Skubic P, Dytman SA, Mueller JA, Nam S, Savinov V. Improved measurement of the form factors in the decay lambda+c-->lambda + nue. PHYSICAL REVIEW LETTERS 2005; 94:191801. [PMID: 16090160 DOI: 10.1103/physrevlett.94.191801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/29/2004] [Indexed: 05/03/2023]
Abstract
Using the CLEO detector at the Cornell Electron Storage Ring, we have studied the distribution of kinematic variables in the decay lambda(+)(c)lambda--> e(+)nu(e). By performing a four-dimensional maximum likelihood fit, we determine the form factor ratio, R= f(2)/f(1) = -0.31 +/- 0.05(stat) +/- 0.04(syst), the pole mass, M(pole) = [2.21 +/- 0.08(stat) +/- 0.14(syst)] GeV/c(2), and the decay asymmetry parameter of the lambda(+)(c), alpha (lambda(c)) = -0.86 +/-0.03(stat) +/- 0.02(syst), for q(2) = 0.67 (GeV/c(2))(2). We compare the angular distributions of the lambda(+)(c) and lambda(-)(c) and find no evidence for CP violation: A(lambda(c)) = (alpha(lambda(c)) + alpha (lambda(c)))/(alpha(lambda(c))-alpha(lambda(c))) = 0.00 +/- 0.03(stat) +/- 0.01(syst) +/- 0.02, where the third error is from the uncertainty in the world average of the CP-violating parameter, A(lambda), for ppi(-).
Collapse
|
100
|
Sanford NA, Robins LH, Gray MH, Kang YS, Nostrand JEV, Stutz C, Cortez R, Davydov AV, Shapiro A, Levin I, Roshko A. Fabrication and analysis of GaN nanorods grown by MBE. ACTA ACUST UNITED AC 2005. [DOI: 10.1002/pssc.200461602] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|